Medical Imaging Reagents and Analysis Equipment

Report Highlights

• Global revenue of the imaging market was worth approximately $21.8 billion in 2008, a figure that further increased to $22.6 billion in 2009. This is projected to reach $29 billion in 2014, at a CAGR of 5.1% between 2009 and 2014.
• The largest segment X-ray and computed tomography was nearly $9.2 billion in 2008; this further increased to $9.3 billion in 2009, this is projected to reach $11.3 billion in 2014, for a 5-year CAGR of 3.9%.
• The Second largest segment ultrasound was nearly $5 billion in 2008; this further increased to $5.1 billion in 2009, this is projected to reach $6.1 billion in 2014, for a 5-year CAGR of 3.4%.

INTRODUCTION

STUDY OBJECTIVES

BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for medical imaging. The key objective is to present a comprehensive analysis of the current market and its future direction as an important tool for the diagnosis of various diseases.

This report explores present and future strategies within the imaging market, including reagents, equipment and systems used for imaging. The improvisation of the market, its setbacks and needs are discussed in this report. Comparisons, usage and the advantages and disadvantages of each imaging system are also discussed in this report. 

A detailed analysis of the imaging industry structure has been conducted. This includes both the imaging reagents and the equipment used. Revenues are broken down by region. Sales figures are estimated for the 5 year period from 2009 through 2014. 

Applications for imaging are also discussed separately in the report, with emphasis on its usage in cardiovascular, oncology, gastrointestinal and central nervous system diseases. The report also covers significant patents and their allotment in each category.

REASONS FOR DOING THIS STUDY

Medical imaging has seen major advances in modern medicine.The “compact revolution” is changing the market of imaging systems. R&D spending, along with increasing competition, patent expiries, new technologies, and an international marketplace are sending the market in new directions. Although the industry did see some setbacks in 2008 due to the economic downturn, new advancements and the need for diagnosis through imaging are helping the market to grow. This study looks at many of the systems affected by these factors. 

Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each system/ technology in light of new technologies, growing competition, and changing customer needs.

INTENDED AUDIENCE

This study contributes to the areas of market growth in diagnosis through imaging from the point of view of manufacturers and users. Analytical companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals and research institutes will find this study to be of interest.

• Examine BCC’s complete catalog of Market Research Reports and place direct orders
• Subscribe to any of BCC’s many industry newsletters
• Read announcements of recently published reports and newly launched newsletters
• Register for BCC’s well-known conferences
• Request additional information on any BCC product
• Take advantage of special offers